Newsletter Archive

51. 12.03.24 -- How To Overcome Immune Rejection In iPSC-based Gene Therapy 12/3/2024
    12/03/24 Drug Discovery Online Newsletter
52. 12.02.24 -- Streamline Your Oral Drug Development Process 12/2/2024

    12/02/24 Drug Discovery Online Newsletter

53. 11.27.24 -- Find The Perfect CDMO Partner For Your Project 11/27/2024
    11/27/24 Drug Discovery Online Newsletter
54. 11.26.24 -- Emerging Partnership Trends In Oligo-Based Medicines 11/26/2024
    11/26/24 Drug Discovery Online Newsletter
55. 11.25.24 -- Choosing The Ideal CDMO Partner For Your Project 11/25/2024
    11/25/24 Drug Discovery Online Newsletter
56. 11.22.24 -- Picking The Right CDMO Partner For Your Project 11/22/2024
    11/22/24 Drug Discovery Online Newsletter
57. 11.19.24 -- Panavance Details IND Prep Ahead Of FDA Submission For Ovarian Cancer Trial 11/19/2024
    11/19/24 Drug Discovery Online Newsletter
58. 11.14.24 -- Take The Next Step Towards Scaling-Up 11/14/2024

    11/14/24 Drug Discovery Online Newsletter

59. 11.13.24 -- Building Resilience In Drug Development: Cost-Efficient Solutions With CDMOs 11/13/2024

    11/13/24 Drug Discovery Online Newsletter

60. 11.12.24 -- iPSC-based Gene Therapy: Applications And Challenges 11/12/2024
    11/12/24 Drug Discovery Online Newsletter